An AI-based framework that applies classifier chains with logistic regression, decision trees, random forests, and their ensemble to capture label dependencies between tests is proposed, demonstrating that classifier chains combined with SHAP offer an effective and interpretable approach for multi-label pathology test recommendation.
Abstract
Diagnostic decision making often relies on a sequence of pathology tests that bridge patient symptoms and final disease diagnosis. Existing clinical decision-support systems typically focus on predicting single diseases and do not explicitly recommend sets of intermediate tests or model dependencies among them. In this paper, we formulate pathology test recommendation as a multi-label classification problem where each case is associated with multiple, interdependent tests. We propose an AI-based framework that applies classifier chains with logistic regression, decision trees, random forests, and their ensemble to capture label dependencies between tests. Experiments on an expert-curated dataset from a private pathology laboratory show that classifier-chain models outperform their independent counterparts, improving F1-score and reducing Hamming loss while maintaining high accuracy across common and rare tests. To enhance trust and transparency, we integrate SHAP-based explainable AI, providing symptom-level attributions that align with established clinical reasoning in most cases. The results demonstrate that classifier chains combined with SHAP offer an effective and interpretable approach for multi-label pathology test recommendation, with potential to support clinicians in selecting appropriate diagnostic tests at an early stage.
A four-step pipeline that mines decision rules in the latent space of an FT-Transformer and translates them back into measurable clinical features that can be evaluated by clinicians is presented.
Majid Lotfian Delouee, Hamed Ayoobi, S. I. '. 't Veld et al.· 0 citations
Artificial Intelligence (AI) has become an important tool in medical diagnostics by enabling models to learn complex relationships between historical patient data and current clinical indicators, supporting earlier and more accurate disease detection. Ovarian cancer remains particularly challenging to diagnose because...
A. Shetty, Prachetas Sujit Chandratreya, Bhargav Sanjeev Gejji et al.· International Conference on...· 0 citations
A reusable optimal-transport recipe for generative explanations and a controlled benchmark for stress-testing whether they localize, and a synthetic-to-real gap: label-free heatmaps that look compelling on planted lesions are not evidence of real localisation.
Early diagnosis and treatment of lung cancer are critical for improving patient survival rates and prognosis. The diagnosis of lung cancer relies on multimodal features, yet the performance of single models remains limited. Current studies have insufficiently explored multimodal feature fusion strategies and the intrin...
Hao-Ran Li, Yang Wang, Fan-Li Jin et al.· Scientific Reports· 0 citations
The proposed framework can serve as an intelligent decision-support tool for prioritizing breast cancer patients and improving resource allocation when healthcare capacity is constrained and its relatively simple and scalable architecture facilitates potential implementation in healthcare environments with limited reso...
Fabián Silva-Aravena, J. Morales, Hugo Núñez Delafuente et al.· Bioengineering· 0 citations
Background/Objectives: Deep learning-based chest X-ray (CXR) analysis has shown strong diagnostic performance; however, conventional ensemble methods typically rely on equal-weight aggregation and do not account for disease-specific model behavior or clinician-defined priorities. Methods: We developed a clinician-confi...
Hui-Chu Chiu, Yu-Hsiang Tsai, Cheng-Hsuan Juan et al.· Diagnostics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.